iLoF: AI-augmented photonics to identify and quantify disease biomarkers
Grant period
2023-08-01 - 2025-07-31
Funding body
European Union
Call number
HORIZON-EIC-2023-ACCELERATOR-01
Grant number
190126414
Identifier
G:(EU-Grant)190126414
Note: iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery & development. Through advanced AI & photonics, we collect massive amounts of data to build a digital library of biomarkers & biological profiles, bringing together world-class physicists, biologists, & data scientists to get life-saving personalized treatments to patients faster. Our platform captures label-free patterns in biological liquid samples, to generate specific patient or disease signatures. The iLoF device generates multiple highly focused, non-destructive laser beams that interrogate the biological sample to obtain a digital signal of its light pattern. That signal is used to detect modifications providing a flexible & agnostic tool that is not limited to a single use or disease. The current project focuses on developing an Alzheimer’s disease (AD) clinical trial patient screening tool.
Recent Publications
There are no publications
Record created 2023-08-27, last modified 2023-08-27